AOM-SOS Version 5.0: Enhanced Psychometric Scale for Acute Otitis Media

Researchers at the University of Pittsburgh have developed an improved version of the Acute Otitis Media Symptom Severity (AOM-SOS) scale, known as AOM-SOS Version 5.0. This new version features enhanced psychometric properties, offering a more precise and reliable tool for assessing the severity of symptoms in children with acute otitis media. The scale now includes six response options, providing a more nuanced evaluation of patient-reported outcomes and aiding in better clinical decision-making.

Description

AOM-SOS Version 5.0 is an updated psychometric scale designed to assess the severity of symptoms in pediatric patients with acute otitis media. The previous version of the scale included three response options, while the new version has expanded to six response options, allowing for a more detailed and accurate assessment. This improvement enhances the scale's sensitivity and specificity, making it a valuable tool for both clinical practice and research. The scale is designed to be easy to use by healthcare providers and can be integrated into routine clinical assessments to monitor patient progress and treatment efficacy.

Applications

• Clinical assessment of acute otitis media in pediatric patients
• Monitoring patient-reported outcomes in clinical trials
• Enhancing decision-making in pediatric healthcare
• Research studies on acute otitis media and related conditions

Advantages

This technology offers several key advantages: it provides a more precise and reliable assessment of symptom severity in children with acute otitis media, enhances the sensitivity and specificity of the evaluation, and supports better clinical decision-making. The expanded response options allow for a more nuanced understanding of patient-reported outcomes, improving the quality of care and research in pediatric health.

Invention Readiness

The AOM-SOS Version 5.0 scale has been developed and tested, demonstrating its improved psychometric properties. Initial in vivo data supports its feasibility and effectiveness in clinical settings. The scale is ready for further validation and implementation in both clinical practice and research. Collaboration with healthcare providers and researchers is being sought to facilitate widespread adoption and integration into clinical workflows.

IP Status

Copyright